Jorgen V Jensen

Title: Jorgen V Jensen: Innovator in Antihemophilic Factor Preparation

Introduction

Jorgen V Jensen is a notable inventor based in Bagsvaerd, Denmark. He has made significant contributions to the field of medical science, particularly in the production of antihemophilic factor preparations. His innovative approach has the potential to improve the quality of life for individuals with hemophilia.

Latest Patents

Jensen holds a patent for a process that produces an antihemophilic factor preparation from human blood plasma. This preparation boasts high solubility and a long half-life, achieved through a unique method involving the thawing of deep-frozen human blood plasma. The process utilizes electromagnetic waves, specifically microwaves or infrared light, to ensure that the temperature of the thawed plasma remains below 10 degrees Celsius. This innovative method allows for the efficient production of a concentrated solution suitable for patient self-injection.

Career Highlights

Jensen is associated with Nordisk Insulinlaboratorium, where he has contributed to advancements in medical technology. His work has focused on enhancing the efficacy and safety of treatments for hemophilia, showcasing his commitment to improving patient care.

Collaborations

Throughout his career, Jensen has collaborated with esteemed colleagues, including Mirella Ezban Rasmussen and Jorgen F Hansen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Jorgen V Jensen's contributions to the field of antihemophilic factor preparation highlight his role as a key innovator in medical science. His patented process not only enhances treatment options for patients but also exemplifies the importance of innovation in healthcare.